ATEC vs CSTL: fair value comparison
Alphatec Holdings, Inc. and Castle Biosciences, Inc. · Updated 2026-10-19
ATEC's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. CSTL has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, ATEC currently ranks higher by quality score.
| ATEC | CSTL | |
|---|---|---|
| Verdict | Awaiting full valuation | No estimate yet |
| Last price | $10.46 | $31.96 |
| 12-month range | $6.99–$22.68 | $18.15–$43.04 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #49 of 301 Healthcare | #50 of 301 Healthcare |
| Quality grade | B | B |
| Leverage | Low | Low |
| Margin trend | Contracting | Contracting |
| Revenue growth | High | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Mixed |
| 52-week position | The bottom quarter | The upper-middle quarter |
Full single-stock breakdowns: ATEC fair value analysis · CSTL fair value analysis